Literature DB >> 10448316

Increased serum concentrations of growth factor receptors and Neu in workers previously exposed to asbestos.

N Lahat1, P Froom, E Kristal-Boneh, C Cohen, Y Lerman, J Ribak.   

Abstract

OBJECTIVES: Epidermal growth factor receptor (EGFR) and oncogene Neu belong to a family of growth factor receptors which may play a part in carcinogenesis. Although increased serum concentrations of Neu and EGFR have been shown in several patients with asbestosis who later developed cancer, serum concentrations have not been studied in workers exposed in the past to asbestos but without asbestos related diseases.
METHODS: Serum concentrations of secreted growth factor receptors were studied in 300 workers exposed in the past to asbestos and the results were compared with those of 70 controls.
RESULTS: In the controls 4.3% (3/70) had EGFR values > 912 units/ml, compared with 39% (117/299) of the exposed group (p < 0.001). The difference in high values was even more pronounced for Neu with 4.3% of controls having Neu values > 2580 fmol/ml compared with 72% (216/299) of the exposed workers (p < 0.001). Pleural plaques predicted lower serum concentrations of EGFR but not lower Neu concentrations, and this finding remained significant after adjustment for age, exposure time, smoking, and time from initial exposure.
CONCLUSIONS: Enhanced secretion of EGFR and Neu was found in a large cohort of retired asbestos workers with a wide range of exposure and latency periods. They did not have asbestosis or cancer and their EGFR values were higher in those without plaques. Further studies are needed to confirm our results, to determine the source of the secreted growth factor receptors, and to study their possible value as risk factors in the development of cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448316      PMCID: PMC1757700          DOI: 10.1136/oem.56.2.114

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  17 in total

1.  Serum oncoproteins and growth factors in asbestosis and silicosis patients.

Authors:  P W Brandt-Rauf; S Smith; K Hemminki; H Koskinen; H Vainio; H Niman; J Ford
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

2.  Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.

Authors:  C L Zanella; J Posada; T R Tritton; B T Mossman
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

3.  An autocrine mitogenic activity produced by a pleural human mesothelioma cell line.

Authors:  B Lauber; M Leuthold; D Schmitter; J Cano-Santos; R Waibel; R A Stahel
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

6.  Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.

Authors:  M Ramael; K Segers; C Buysse; J Van den Bossche; E Van Marck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 7.  Growth factors and cancer.

Authors:  S A Aaronson
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

8.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

Authors:  P P Di Fiore; J H Pierce; M H Kraus; O Segatto; C R King; S A Aaronson
Journal:  Science       Date:  1987-07-10       Impact factor: 47.728

9.  A monoclonal antibody to the human epidermal growth factor receptor.

Authors:  M D Waterfield; E L Mayes; P Stroobant; P L Bennet; S Young; P N Goodfellow; G S Banting; B Ozanne
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

10.  Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans.

Authors:  P W Brandt-Rauf; J C Luo; W P Carney; S Smith; I De Vivo; C Milling; K Hemminki; H Koskinen; H Vainio; A I Neugut
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.